Literature DB >> 2773308

Comparative studies on the effect of fenbendazole on the liver and liver microsomal enzymes in goats, quail and rats.

R R Dalvi1.   

Abstract

To compare the effect of fenbendazole on the liver and liver microsomal mono-oxygenases of goats, quail and rats, an oral dose of 25 mg/kg was administered to the animals daily for 9 consecutive days. On the tenth day, blood samples and livers were collected from both the control and the treated animals for preparation of serum and microsomes respectively. Determination of the activities of sorbitol dehydrogenase (SDH, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in the serum samples showed that there was no significant increase in the activities of these enzymes in the treated animals as compared to their corresponding controls, suggesting no liver damage. Similarly, no significant difference in the amount of microsomal cytochrome P-450 was found between the control and the treated animals of the same species. Compared to their respective controls, the activities of microsomal benzphetamine N-demethylase and aniline hydroxylase were almost unchanged in the treated goats and rats. However, fenbendazole treatment appeared to enhance the activity of these two microsomal enzymes in quail. The results indicate that fenbendazole is not liver toxic to goats, quail or rats at a dose rate of 25 mg/kg.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2773308     DOI: 10.1007/BF00346723

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  11 in total

1.  Inhibitors of hepatic mixed function oxidases--II. Some benzimidazole, benzoxazole and benzothiazole derivatives.

Authors:  G M Holder; P J Little; A J Ryan; T R Watson
Journal:  Biochem Pharmacol       Date:  1976-12-15       Impact factor: 5.858

2.  Hepatic cytochrome P-450 dependent drug metabolizing activity in rats, rabbits and several food-producing species.

Authors:  R R Dalvi; V A Nunn; J Juskevich
Journal:  J Vet Pharmacol Ther       Date:  1987-06       Impact factor: 1.786

3.  Inducing effect of albendazole on rat liver drug-metabolizing enzymes and metabolite pharmacokinetics.

Authors:  H Souhaili-el Amri; X Fargetton; E Benoit; M Totis; A M Batt
Journal:  Toxicol Appl Pharmacol       Date:  1988-01       Impact factor: 4.219

4.  The oxidative metabolism of fenbendazole: a comparative study.

Authors:  C R Short; W Flory; L C Hsieh; S A Barker
Journal:  J Vet Pharmacol Ther       Date:  1988-03       Impact factor: 1.786

5.  Disposition of fenbendazole in the goat.

Authors:  C R Short; S A Barker; L C Hsieh; S P Ou; L E Davis; G Koritz; C A Neff-Davis; R F Bevill; I J Munsiff; G C Sharma
Journal:  Am J Vet Res       Date:  1987-05       Impact factor: 1.156

6.  Sulfoxidation of albendazole by a cytochrome P450-independent monooxygenase from rat liver microsomes.

Authors:  X Fargetton; P Galtier; P Delatour
Journal:  Vet Res Commun       Date:  1986-07       Impact factor: 2.459

7.  Studies on comparative drug metabolism by hepatic cytochrome P-450-containing microsomal enzymes in quail, ducks, geese, chickens, turkeys and rats.

Authors:  R R Dalvi; V A Nunn; J Juskevich
Journal:  Comp Biochem Physiol C       Date:  1987

8.  Effects of Syphacia muris and the anthelmintic fenbendazole on the microsomal monooxygenase system in mouse liver.

Authors:  G Mohn; E M Philipp
Journal:  Lab Anim       Date:  1981-04       Impact factor: 2.471

9.  Inhibition and induction of microsomal enzymes in rat. A comparative study of four antimycotics: miconazole, econazole, clotrimazole and ketoconazole.

Authors:  C J Niemegeers; J C Levron; F Awouters; P A Janssen
Journal:  Arch Int Pharmacodyn Ther       Date:  1981-05

10.  Involvement of glutathione in the reduction of captan-induced in vivo inhibition of monooxygenases and liver toxicity in the rat.

Authors:  R R Dalvi
Journal:  J Environ Sci Health B       Date:  1988-04       Impact factor: 1.990

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.